BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 19542888)

  • 1. Transplantation tolerance in an age of induced pluripotency.
    Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):321-5. PubMed ID: 19542888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?
    Salewski RP; Eftekharpour E; Fehlings MG
    J Cell Physiol; 2010 Mar; 222(3):515-21. PubMed ID: 20020443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells and nuclear reprogramming.
    Saric T; Hescheler J
    Minim Invasive Ther Allied Technol; 2008; 17(2):64-78. PubMed ID: 18465442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotency: toward a gold standard for human ES and iPS cells.
    Smith KP; Luong MX; Stein GS
    J Cell Physiol; 2009 Jul; 220(1):21-9. PubMed ID: 19326392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte transplantation: waiting for stem cells.
    Haridass D; Narain N; Ott M
    Curr Opin Organ Transplant; 2008 Dec; 13(6):627-32. PubMed ID: 19060554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From pluripotency to distinct cardiomyocyte subtypes.
    David R; Franz WM
    Physiology (Bethesda); 2012 Jun; 27(3):119-29. PubMed ID: 22689787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells.
    Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K
    J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for future histocompatible stem cell therapy.
    Nehlin JO; Barington T
    Biogerontology; 2009 Aug; 10(4):339-76. PubMed ID: 19219637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cells and the challenge of transplantation tolerance.
    Fairchild PJ; Cartland S; Nolan KF; Waldmann H
    Trends Immunol; 2004 Sep; 25(9):465-70. PubMed ID: 15324738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biological properties of pluripotent embryonic stem cells.
    Ohtsuka S; Dalton S
    Gene Ther; 2008 Jan; 15(2):74-81. PubMed ID: 17989701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
    Xia X; Chu J; Chen X
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic stem cell differentiation: emergence of a new era in biology and medicine.
    Keller G
    Genes Dev; 2005 May; 19(10):1129-55. PubMed ID: 15905405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of induced pluripotent stem cells.
    Okita K; Nagata N; Yamanaka S
    Circ Res; 2011 Sep; 109(7):720-1. PubMed ID: 21921270
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of stem cells in kidney disease.
    Chhabra P; Brayman KL
    Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryonic and adult stem cell therapy.
    Brignier AC; Gewirtz AM
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S336-44. PubMed ID: 20061008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dive into the stem cells world.
    Fagoonee S; Pellicano R; Altruda F
    Panminerva Med; 2009 Mar; 51(1):1-3. PubMed ID: 19352304
    [No Abstract]   [Full Text] [Related]  

  • 19. Harnessing stem cells and dendritic cells for novel therapies.
    Markowicz S
    Acta Pol Pharm; 2008; 65(6):625-32. PubMed ID: 19172843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of membrane proteins expressed specifically in pluripotent murine embryonic stem cells.
    Intoh A; Kurisaki A; Yamanaka Y; Hirano H; Fukuda H; Sugino H; Asashima M
    Proteomics; 2009 Jan; 9(1):126-37. PubMed ID: 19053146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.